Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 8.04
0.00 (0.00%)
At close: Sep 25, 2026
Svas Biosana Revenue
Svas Biosana had revenue of 71.90M EUR in the half year ending June 30, 2026, with 19.85% growth. This brings the company's revenue in the last twelve months to 141.55M, up 5.98% year-over-year. In the year 2025, Svas Biosana had annual revenue of 142.65M with 16.20% growth.
Revenue (ttm)
141.55M
Revenue Growth
+5.98%
P/S Ratio
0.30
Revenue / Employee
406.77K
Employees
348
Market Cap
41.99M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 142.65M | 19.89M | 16.20% |
| Dec 31, 2024 | 122.77M | 429.37K | 0.35% |
| Dec 31, 2023 | 122.34M | 20.06M | 19.61% |
| Dec 31, 2022 | 102.28M | 20.76M | 25.47% |
| Dec 31, 2021 | 81.52M | 3.81M | 4.91% |
| Dec 31, 2020 | 77.71M | 2.69M | 3.59% |
| Dec 31, 2019 | 75.01M | 4.94M | 7.05% |
| Dec 31, 2018 | 70.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.71B |
| Amplifon | 2.40B |
| DiaSorin | 1.18B |
| EL.En. | 611.40M |
| GPI S.p.A. | 546.18M |
| Talea Group | 132.17M |
| Farmacosmo | 56.13M |
| EuKedos | 52.91M |